A medical AI tool's missed diagnosis does not, by itself, establish gross negligence. The conduct may reach that level only when the full facts show an extreme lack of care under the law of the governing jurisdiction. The title does not identify a tool, patient, jurisdiction, or court case, so the incident cannot be verified. A 2026 BMJ assessment reported no identified cases in which an AI model contributed to a delayed cancer diagnosis, underscoring the need to prove what happened in the specific patient's care in the BMJ assessment.
Table of Contents
- What separates negligence from gross negligence?
- Did the software cause the missed diagnosis?
- Was the clinician expected to verify the result?
- Who might be responsible for the harm?
- What should an injured patient preserve?
What separates negligence from gross negligence?
Ordinary negligence generally concerns a failure to use reasonable care. Gross negligence requires substantially worse conduct, but the precise threshold depends on state law and the case's facts. California's model jury instruction, for example, describes gross negligence as either a failure to provide even scant care or an extreme departure from ordinary conduct.
Under that standard, one false negative from an AI tool would not automatically be enough according to the Judicial Council of California. The stronger question is how people responded to the software. Gross negligence becomes more plausible if clinicians ignored obvious symptoms, contradictory test results, repeated warnings, or required review procedures. Continued use after known dangerous failures could also matter.
Did the software cause the missed diagnosis?
A bad outcome and a defective process are not the same thing. The investigation must determine whether the software missed the finding, whether a clinician independently reviewed the evidence, and whether timely diagnosis would probably have changed the patient's care or injury. medical AI can miss cancers that clinicians detect—and detect cancers that clinicians miss.
In a 24,543-woman mammography cohort, AI-CAD missed 12 of 148 confirmed cancers recalled by radiologists, while identifying five cancers radiologists missed the RSNA study reported. Those results support using AI as an aid, not assuming it caused every diagnostic delay. The research involved screened women in Korea and a retrospective secondary analysis, so it cannot establish how another product or hospital performed.
Was the clinician expected to verify the result?
Responsibility may depend on the tool's intended role. A program that highlights suspicious areas raises different questions from one presented as making a final diagnosis.
The FDA says software interpreting the clinical significance of a medical image or signal may fall under medical-device oversight. Its clinical-decision-support framework also emphasizes whether clinicians can independently review the basis of recommendations instead of relying primarily on software for one patient's diagnosis or treatment the FDA explains. Important questions include:.
- Did a qualified clinician review the original image, signal, or laboratory result?
- Did the hospital's protocol require a second reading or follow-up test?
- Were symptoms or earlier findings inconsistent with the software output?
- Did the product display limitations, warnings, or confidence information?
- Did time pressure, poor training, or workflow design turn an advisory output into a final answer?
Who might be responsible for the harm?
Potential responsibility may extend beyond the person who delivered the diagnosis. Depending on the evidence and local law, an investigation may examine the clinician, medical practice, hospital, software developer, device manufacturer, or outside service provider. Their roles should not be treated as interchangeable.
A clinician may have failed to review available evidence; a hospital may have adopted an unsafe workflow; or a product may have produced unreliable results when used as intended. Contracts, access logs, policies, and product instructions can clarify who controlled each decision. FDA authorization alone does not decide civil liability. Authorization addresses applicable premarket requirements for the device's intended use, while a lawsuit focuses on the specific conduct, causal chain, injury, and available legal claims.
What should an injured patient preserve?
Evidence can disappear through routine record changes, software updates, and fading memories. A patient considering a claim should promptly request the complete medical record and avoid relying only on the after-visit summary.
Useful material may include: A lawyer evaluating the case will also need the applicable filing deadline and jurisdiction-specific gross-negligence standard. Preserve the original files and their metadata rather than keeping only screenshots or rewritten summaries.
- Original images, signals, pathology materials, and test reports
- The AI output, confidence score, alert, or marked-up image
- Audit logs showing who viewed, changed, or approved the result
- Product name, software version, and date of use
- Hospital policies, training materials, and review requirements